Jaykant Vora

Jaykant Vora

Auto-generated profile, based on publicly available information

Jaykant Vora

A Department of Pharmacognosy and Phytochemistry , B. V. Patel Pharmaceutical Education and Research Development (PERD) Centre , Ahmedabad , Gujarat , India

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Informatics in Medicine Unlocked
Verified
Journal Article
Open access
JVJaykant Vora
Jaykant Vora
ASAnshu Srivastava
Anshu Srivastava
HMHashmukh Modi
Hashmukh Modi

2 January 2018 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
JVJaykant Vora
Jaykant Vora
SPShivani Patel
Shivani Patel
SSSonam Sinha
Sonam Sinha
SSSonal Sharma
Sonal Sharma
ASAnshu Srivastava
Anshu Srivastava
NSNeeta Shrivastava
Neeta Shrivastava
AIDS is one of the multifaceted diseases and this underlying complexity hampers its complete cure. The toxicity of existing drugs and emergence of multidrug-resistant virus makes the treatment worse. Development of effective, safe and low-cost anti-HIV drugs is among the top global priority. Exploration of natural resources may give ray of hope to develop new anti-HIV leads. Among the various therapeutic targets for HIV treatment, reverse transcriptase, protease, integrase, GP120, and ribonuclease are the prime focus. In the present study, we predicted potential plant-derived natural molecules for HIV treatment using computational approach, i.e. molecular docking, quantitative structure activity relationship (QSAR), and ADMET studies. Receptor-ligand binding studies were performed using three different software for precise prediction – Discovery studio 4.0, Schrodinger and Molegrow virtual docker. Docking scores revealed that Mulberrosides, Anolignans, Curcumin and Chebulic acid are promising candidates that bind with multi targets of HIV, while Neo-andrographolide, Nimbolide and Punigluconin were target-specific candidates. Subsequently, QSAR was performed using biologically proved compounds which predicted the biological activity of compounds. We identified Anolignans, Curcumin, Mulberrosides, Chebulic acid and Neo-andrographolide as potential natural molecules for HIV treatment from results of molecular docking and 3D-QSAR. In silico ADMET studies showed drug-likeness of these lead molecules. Structure similarities of identified lead molecules were compared with identified marketed drugs by superimposing both the molecules. Using in silico studies, we have identified few best fit molecules of natural origin against identified targets which may give new drugs to combat HIV infection after wet lab validation.

28 December 2018 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
JVJaykant Vora
Jaykant Vora
SPShivani Patel
Shivani Patel
SSSonam Sinha
Sonam Sinha
SSSonal Sharma
Sonal Sharma
ASAnshu Srivastava
Anshu Srivastava
NSNeeta Shrivastava
Neeta Shrivastava
The transmission of mosquito-borne Chikungunya virus (CHIKV) has large epidemics worldwide. Till date, there are neither anti-viral drugs nor vaccines available for the treatment of Chikungunya. Accumulated evidences suggest that some natural compounds i.e. Epigallocatechin gallate, Harringtonine, Apigenin, Chrysin, Silybin etc. have the capability to inhibit CHIKV replication in vitro. Natural compounds are known to possess less or no side effects. Therefore, natural compound in its purified or crude extracts form could be the preeminent and safe mode of therapies for Chikungunya. Wet lab screening and identification of natural compounds against Chikungunya targets is a time consuming and expensive exercise. In the present study, we used in silico techniques like receptor-ligand docking, Molecular dynamic (MD), 3D-QSAR and ADME properties to screen out potential compounds. Aim of the study is to identify potential lead/s from natural sources using in silico techniques that can be developed as a drug like molecule against Chikungunya infection and replication. Three softwares were used for molecular docking studies. Potential ligands selected by docking studies were subsequently subjected 3D-QSAR studies to predict biological activity. Based on docking scores and pIC50 value, potential anti-Chikungunya compounds were identified. Best docked receptor-ligands were also subjected to MD for more accurate estimation. Lipinski’s rule and ADME studies of the identified compounds were also studied to assess their drug likeness properties. Results of in silico findings, led to identification of few best fit compounds of natural origin against targets of Chikungunya virus which may lead to discovery of new drugs for Chikungunya.

1 May 2018 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
SSSonam Sinha
Sonam Sinha
SSSonal Sharma
Sonal Sharma
JVJaykant Vora
Jaykant Vora
HSHeta Shah
Heta Shah
ASAnshu Srivastava
Anshu Srivastava
NSNeeta Shrivastava
Neeta Shrivastava

25 March 2020 in Current HIV Research
Verified
Journal Article
Closed access
PDF file
JVJaykant Vora
Jaykant Vora
Mohd AtharMohd Athar
Mohd Athar
SSSonam Sinha
Sonam Sinha
PJPrakash C. Jha
Prakash C. Jha
NSNeeta Shrivastava
Neeta Shrivastava
Background: Despite intense efforts, AIDS is difficult to tackle by current anti-retroviral therapy (ART) due to its side effects; therefore, there is an urgent need to discover potential, multitarget and low-cost anti-HIV compounds. Objective: We have shown that few phytocompounds can potentially inhibit the prime targets of HIV namely GP120 envelope protein, reverse transcriptase, protease, integrase and ribonulcease. In this study, top ranked prioritized compounds were subjected to Molecular Dynamics (MD) simulation in order to study the conformational dynamics and integrity of crucial interaction in the receptor sites. Method: The system was built for selected protein-ligand complex using TIP3P water model and OPLS_2005 force field. Trajectories were recorded up to 20 ns simulation time in Desmond module of Schrödinger software. Conclusion: These findings can aid in the designing of the structural properties for more effective anti-HIV compounds against the given targets.

19 January 2023 in Journal of microbiology, biotechnology and food sciences
Verified
Journal Article
Open access
PDF file
JVJaykant Vora
Jaykant Vora
SSSonam Sinha
Sonam Sinha
SSSonal Sharma
Sonal Sharma
ASAnshu Srivastava
Anshu Srivastava
NSNeeta Shrivastava
Neeta Shrivastava
Endophytes provide a plethora of potential substances that are used in modern medicine. There is an emergence of interest to discover potential compounds from endophytes due to their abundant availability from renewable sources, and low cost relative to chemically synthesized compounds. Studies have shown that Morus alba plant has potential antioxidant and antibacterial activities. Hence, in the present study we deals with the bioprospecting of endophytes of Morus alba. Stem bark of M. alba was collected from different regions of Gujarat. Total 13 bacteria and 14 fungal endophytes were isolated from the collected samples. Among 27 endophytic isolates, the extract of four isolates showed significant antibacterial activity with a diameter zone ranged from 8.0±0.0 to 22.33±1.262 mm with considerable minimum inhibitory concentration (MIC) values. These four extracts also showed significant inhibition of reactive oxygen species in 1,1-diphenyl-2-picrylhydrazyl (DPPH) assay. Triterpenoids, flavonoids, and phenols were present in these extracts which might be responsible for these bioactivities. Results of this study concluded that these endophytes isolated from the stem bark of Morus alba L. have an important bioactivities in vitro. These extracts may prove good candidate for the antibacterial and antioxidant agents and can be exploited in pharmaceuticals after further development.